MG Nutrición 3G

Project: Demonstration of efficacy of genetically personalised nutrition for disease prevention

This project aims to demonstrate the effectiveness of personalised nutrition recommendations in preventing diseases based on a genetic test that allows knowing the individual predisposition for eleven common diseases among older citizens. The project will be carried out by cross-matching medical and nutritional records with the genetic data of 1000 volunteers.

  • Sectors involved: Health & ICT

  • Partner country: Spain

  • Voucher(s): Demonstration Voucher

  • Consortium: Yes

About MG Nutrición 3G S.L.
Nutrition 3g offers precision nutritional recommendations based on the genetic pattern of each individual with the aim of improving quality of life and get a better healthy aging by customized dietary guidelines.


Sequplexing Multiplex SL (Seqplexing)
Born as an INCLIVA (Instituto de Investigación Sanitaria Hospital Clínico de Valencia) spin-off company based on protocols and products with commercialisation potential, the mission behind Seqplexing is to improve and simplify genetic diagnosis by developing innovative solutions for the detection and analysis of clinically relevant genetic alterations. Seqplexing launched small scale sales of current products and services and will start with large Health Services Companies in the next months.